Puma Biotechnology | Bienes

Precio De Mercado
6.82
Cambio Diario
0.02 0.29%
Mensual
6.23%
Anual
138.46%
Q1 Expectativa
5.65




Bienes Cambio Fecha
Agios Pharmaceuticals USD 1.3B 88.48M 2025-12
Alnylam Pharmaceuticals USD 4.97B 114.67M 2025-12
Amgen USD 90.59B 445M 2025-12
Biogen USD 29.44B 232M 2025-12
BioMarin Pharmaceutical USD 7.61B 158.53M 2025-09
Daiichi Sankyo JPY 3.82T 252.52B 2025-12
Esperion Therapeutics USD 364.02M 16.93M 2025-09
Exelixis USD 2.84B 20.87M 2025-12
Gilead Sciences USD 59.02B 490M 2025-12
Glaxosmithkline GBP 82.45B 23.19B 2025-09
Incyte USD 6.96B 627.62M 2025-12
MacroGenics USD 270.76M 25.34M 2025-09
Moderna USD 12.34B 203M 2025-12
Novartis USD 107.29B 2.89B 2025-09
Pfizer USD 208.73B 2.64B 2025-09
PTC Therapeutics USD 2.64B 9.54M 2025-09
Puma Biotechnology USD 202.86M 7.95M 2025-09
Regeneron Pharmaceuticals USD 40.56B 389.3M 2025-12
Roche Holding CHF 100.7B 5.94B 2025-12
Sangamo BioSciences USD 97.56M 11.39M 2025-06
Sarepta Therapeutics USD 3.49B 186.38M 2025-09
Takeda JPY 15.41T 938.47B 2025-12
TG Therapeutics USD 1.03B 322.41M 2025-09
Ultragenyx Pharmaceutical USD 1.53B 341.56M 2025-12
Vanda Pharmaceuticals USD 488.95M 112.19M 2025-12
Vertex Pharmaceuticals USD 25.64B 780.7M 2025-12


Puma Biotechnology Bienes - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Feb 2026.